(Irvine, CA, December 8, 2019) – Modern Healthcare magazine released its 2019 list of 100 Most Influential People in Healthcare, including Annette Walker, President of City of Hope Orange County on this prestigious list. The national program honors individuals who are selected by their peers and the senior editors of Modern Healthcare to be the most influential individuals in health care, in terms of leadership and impact. Walker shares the health care industry’s highest honor alongside Seema Verma, Jeff Bezos, Senator Elizabeth Warren, President Trump, and more
“I am humbled to represent City of Hope among the top leaders in American health care. This Modern Healthcare honor is a testimony to the outstanding efforts and vision of the City of Hope team and underscores the impact of our strategy in Orange County, California,” says Walker. “We are leading the way, doing extraordinary work, and making an impact on this great community as we expand the reach of our lifesaving treatment and research.”
“This year’s selection process was contentious and difficult. Many healthcare organizations made bold strides in the continued transformation of the industry,” commented Aurora Aguilar, Modern Healthcare editor. “The honorees chosen this year by Modern Healthcare and our readers are those who were fearless in their risky strategies and unapologetic in their rationale.”
Walker is a visionary health care leader who has designed and executed enterprise-wide transformation for some of the country’s largest health organizations. She currently leads the development of a 21st-century cancer campus for City of Hope, named by U.S. News & World Report as the best cancer hospital in California. In her role, Annette is realizing an extraordinary vision to transform American cancer care by building a $1 billion world-class cancer center and network of unparalleled scale for Orange County, California, the country’s sixth most populous county. The unprecedented initiative, part of City of Hope’s commitment to eradicating cancer, will bring breakthrough research, highly specialized treatment, phase I-II clinical trials and early detection and prevention closer to home for Orange County’s 3.2 million residents.